With several important initiatives underway at Moffitt Cancer Center, one of the greatest challenges is prioritizing them in a way that is most impactful for its field and patients, said President and ...

Neoadjuvant immunotherapy is associated with high rates of event-free survival in patients with resectable melanoma.

John Scott Dalglish, 66, passed away on June 30, 2025, at MD Anderson Cancer Center in Houston, Texas. Scott was born ...